Startup profile · funding coverage
Alchemy Health
End-to-end infrastructure for in-house pharmacy programs at HIV/HCV clinics.
Stage
seed
Status
private
Coverage
full
Why Alchemy Health is interesting
Founders from Truepill and global HIV access work — targets safety-net clinics where pharmacy friction drives adherence gaps.
Key facts
- Seed (2024): $31M led by a16z Bio + Health with AlleyCorp, Twine Ventures, Springbank (company press)
- Magic Johnson and Sandberg Bernthal also participated (press)
Investors in our directory
Funds linked from Alchemy Health's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Biotech & Life Sciences
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Related funding articles
Venture Capital Tracker pieces that cover Alchemy Health's financing or category context.
FAQs about Alchemy Health
Funding context and why this company shows up in venture coverage.
Alchemy Health enables clinics — especially HIV/HCV safety-net providers — to run in-house pharmacy programs that reduce friction between diagnosis, prescribing, and medication pickup.
a16z Bio + Health led the $31M seed (2024). AlleyCorp (/fund/alleycorp) participated. See /fund/andreessen-horowitz.
Seed-stage private company after the 2024 $31M round.
Founders from Truepill and global HIV access work target adherence gaps where pharmacy logistics — not clinical protocols — drive treatment drop-off.
No — remains private as of July 2026.
Last updated: 2026-07-24